Insulet

Yahoo Finance • 21 hours ago

Danaher Achieves #26 Analyst Rank, Surpassing Insulet

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Danaher Corp (Symbol: DHR) has taken over the #26 spot from Insulet Corp (Symbol: PODD), according to ETF Channel. Below is a cha... Full story

Yahoo Finance • 5 days ago

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Novartis in focus

Wall Street's major averages closed deep in the red on Friday, with oil sustaining higher prices even as Israeli Prime Minister Netanyahu said the country is helping to reopen the Strait of Hormuz. The benchmark S&P 500 ended -1.5%, while... Full story

Yahoo Finance • 9 days ago

1 Healthcare Stock with Exciting Potential and 2 We Avoid

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 3.6% ga... Full story

Yahoo Finance • 10 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD).  Such investors are advised to contact Danielle Peyton at newac... Full story

Yahoo Finance • 12 days ago

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment

On February 17, 2026, Parkman Healthcare Partners disclosed a new position in EyePoint(NASDAQ:EYPT), acquiring 1,088,033 shares in the fourth quarter. What happened According to a Securities and Exchange Commission (SEC) filing dated Feb... Full story

Yahoo Finance • 12 days ago

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement

On February 17, 2026, Parkman Healthcare Partners disclosed a new position in Masimo Corporation(NASDAQ:MASI), acquiring 200,000 shares in the fourth quarter worth an estimated $26.01 million at quarter’s end. What happened According to... Full story

Yahoo Finance • 14 days ago

Iran War Drags Stocks Lower

The S&P 500 Index ($SPX) (SPY) on Friday closed down -0.61%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.26%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.62%.  March E-mini S&P futures (ESH26) fell -0.60%, and M... Full story

Yahoo Finance • 14 days ago

Stock Market Today: Nasdaq Drops As Oil Up After Bessent's Remark; Insulin Stock Takes A Plunge (Live Coverage)

The Dow Jones index faded Friday after surprise inflation and GDP data. Adobe stock plunged on earnings. Continue Reading... Full story

Yahoo Finance • 14 days ago

Stocks Erase Early Gains on Iran War Anxiety

The S&P 500 Index ($SPX) (SPY) today is down -0.18%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.10%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.30%.  March E-mini S&P futures (ESH26) are down -0.19%, and March E-mini Na... Full story

Yahoo Finance • 14 days ago

Stocks making the biggest moves midday: Adobe, Ulta Beauty, Insulet, Klarna, Once Upon a Farm & more

Check out some of the companies making the biggest moves midday: Adobe — The software giant saw shares tumble more than 5%. CEO Shantanu Narayen said that he would step down from his post after a successor has been named. Narayen will rema... Full story

Yahoo Finance • 14 days ago

Nasdaq, S&P, Dow futures rise ahead of PCE, GDP

[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Stock index futures rose on Friday as investors prepared for a busy morning of economic data, with GDP and PCE figures topping the calendar. Dow futures (INDU [https://se... Full story

Yahoo Finance • 28 days ago

Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating

Insulet Corporation (NASDAQ:PODD) is among the 10 High Growth S&P 500 Stocks to Buy Now.Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating Truist on February 19, 2026, lowered its price target... Full story

Yahoo Finance • last month

Stocks Settle Higher on Signs of US Economic Strength

The S&P 500 Index ($SPX) (SPY) on Wednesday closed up +0.56%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.26%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.80%.  March E-mini S&P futures (ESH26) rose +0.52%, and Marc... Full story

Yahoo Finance • last month

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * Analog Devices (ADI [https://seekingalpha.com/symbol/ADI]) * SolarEdge Technologies (SEDG [https://seekingalpha.com/symbol/SEDG]) * Fiverr International Ltd. (FVRR [htt... Full story

Yahoo Finance • last month

Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what to look for. Insulet beat analysts’ revenue expectations by 3.9% last quarter, reporting revenues of $706.3 million,... Full story

Yahoo Finance • last month

What Insulet (PODD)'s Middle East Omnipod 5 Launch Means For Shareholders

In early February 2026, Insulet announced that its Omnipod 5 Automated Insulin Delivery System and new Omnipod Discover data platform are now available across Saudi Arabia, Kuwait, Qatar, and the UAE, extending Omnipod 5’s reach to 19 coun... Full story

Yahoo Finance • 2 months ago

What Analysts Think Is Shifting The Story For Insulet (PODD) And Its Edge Now

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Insulet’s fair value estimate has been nudged from US$373.84 to US$369.64, and the discount rate used in the analysis has b... Full story

Yahoo Finance • 2 months ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates, compatible with Abbott and Dexcom continuous glucose sensors Inaugural launch of Omnipod Discover... Full story

Yahoo Finance • 3 months ago

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of the iDose TR launch and a robust product pipeline. However, stiff competition is a concern. Shares of this Zacks Rank #3 (Hold) company have gained 12.5% so far this year c... Full story

Yahoo Finance • 3 months ago

Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026

Insulet Corporation (NASDAQ:PODD) is one of the best growth stocks to buy in 2026. On December 18, Truist lowered the firm’s price target on Insulet to $390 from $412 with a Buy rating on the shares. This sentiment was posted as part of th... Full story